๐ฐ Drug Controller General News
Page 2 - Drug Controller General News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Drug Controller General. Real-time updates on events, politics, business and more.
April 6, 2024
Bharat biotech: Bharat Biotech seeks nod for phase-3 trials of intranasal Covid-19 vaccine as booster dose | India News - Rashtra News : Rashtra News #bharat #biotech #Bharat #Biotech #seeks #nod #phase3 #trials #intranasal #Covid19 #vaccine #booster #dose #India #News #Times #India HYDERABAD: Bharat Biotech has sought the Drug Controller General of India's approval to
March 13, 2024
The guidelines prohibit companies from conducting continued medical education (CME) workshops in foreign countries.
February 15, 2024
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
February 14, 2024
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
February 14, 2024
Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO, Feb. 14, 2024 /PRNewswire/ -- Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and...
February 13, 2024
As the countryโs apex health regulatory body intensifies its scrutiny of drug manufacturing practices throughout India, it has rolled out fresh guidelines for sampling drugs, cosmetics, and medical devices.
February 9, 2024
Swiss pharmaceutical firm Roche has sounded alarm against clinical trials conducted by Zydus Lifesciences on its biologic drug Perjeta, a widely-used breast cancer treatment. The Swiss company has filed a complaint against the Indian drug maker over alleged critical gaps in the clinical trial of a drug originally developed by Roche
January 19, 2024
Drug maker Indian Immunologicals on Friday launched India's first indigenously developed Hepatitis A vaccine.The two-dose vaccine, Havisure, represents a significant step forward in India's fight against Hepatitis A and is poised to play a ...
January 15, 2024
India offers a groundbreaking medication, Inclisiran, designed to lower high cholesterol. This treatment ensures effective and consistent reduction in bad cholesterol with just two injections a year. - High Cholesterol: What is Inclisiran? Indias New Approach to Lower Cholesterol With THIS Two-Jabs-a-Year Treatment
January 14, 2024
Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low with just two doses a year, doctors, while hailing the advance, contend that the drug is expensive and stressed ...